Researchers from Huddersfield University have stated that the benefits of using steroid-containing inhalers and nebulisers during the COVID-19 pandemic outweigh the risks, despite warnings to the contrary. Previously, the WHO advised back in March that steroids used in inhalers and nebulisers, such as those prescribed to people with asthma or COPD, could have a negative
Report from Asthma UK has found that deaths from asthma attacks are the highest they have been in the last decade and increased by more than 33% over the last ten years. By analysing data from the Office for National Statistics (ONS), they revealed that more than 1,400 people died from an asthma attack last
Asthma UK has revealed that those with asthma are rationing their medication due to prescription costs which is causing avoidable asthma attacks and extra hospital admissions. Recent reports by the charity has claimed that more than a million people in England are having to ‘pay to breathe’ and are at risk of having a life-threatening
Patients with severe and uncontrolled asthma found that taking AstraZeneca’s experimental drug benralizumab in a late-stage study either significantly reduced the need or stopped altogether their intake of oral corticosteroids (OCS), the drug was also shown to dramatically cut related hospitalisations.